InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Finley John David, Chief Financial Officer. Officer active across 1 companies, notably Palisade Bio, INC.. Aggregated, 6 filings have been recorded. Total volume traded: €23k. The latest transaction was disclosed on 29 April 2022 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
012,545 shares0
Common Stock
SEC:0001209191-22-026450:0·
€7,4277,500 shares@ €0.99030.0020% mcap32.4% of flow
Common Stock
SEC:0001209191-22-021051:0·
Ideal exit: 19 Dec 2022 (T+270)
€4,1632,000 shares@ €2.081453.8% of flow
Common Stock
SEC:0001209191-21-057319·
Ideal exit: 18 Jun 2022 (T+270)
€4,1632,000 shares@ €2.08140.0011% mcap18.2% of flow
Common Stock
SEC:0001209191-21-057319:0·
Ideal exit: 18 Jun 2022 (T+270)
€3,5791,600 shares@ €2.237146.2% of flow
Common Stock
SEC:0001209191-21-053803·
Ideal exit: 24 May 2022 (T+270)
€3,5791,600 shares@ €2.23710.0010% mcap15.6% of flow
Common Stock
SEC:0001209191-21-053803:0·
Ideal exit: 24 May 2022 (T+270)
6 of 6 declarations
About Finley John David
Finley John David is the Chief Financial Officer at Palisade Bio, Inc. He is responsible for financial management and economic strategy for the company. His expertise in finance is essential to ensure the financial health and sustainable growth of Palisade Bio.
